Cannabis News and Research

Latest Cannabis News and Research

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute.

4 Nov 2013

New all-natural technology can eliminate molds and pesticides in cannabis products

As medical marijuana states crack down on pesticides, molds and other adulterants in cannabis products, Neutra Corp. is helping to develop new technology to keep patients safe from potentially harmful contamination.

30 Oct 2013

Regular cannabis users have increased levels of impulsive behaviour, reveals research

New cocaine and cannabis research reveals that regular cannabis users have increased levels of impulsive behaviour. It had previously been argued that this increased impulsivity after cannabis administration was only experienced by occasional users, but that regular users were no longer affected in this way.

29 Oct 2013

Medical Cannabis Payment Systems announces marketing features for S2S Seed-to-Sale solution

Medical Cannabis Payment Systems, Inc. today announced some of the marketing features for their innovative S2S Seed-to-Sale solution. S2S will provide retailers and providers with powerful tools to grow business and maximize efficiency, joining with their customers to move the medical cannabis marketplace to the next level.

21 Oct 2013

Neutra working to help end staph infections in locker rooms

With football season now in full swing, a dangerous, highly resistant strain of staph infections is plaguing locker rooms across the country, potentially costing organizations such as the NFL and NCAA millions of dollars. Neutra Corp., a growing provider of all-natural wellness solutions, is working to help end the costly epidemic.

17 Oct 2013

Study: Non-hallucinogenic components of cannabis may act as effective anti-cancer agents

The anti-cancer properties of tetrahydrocannabinol (THC), the primary hallucinogenic component of cannabis, has been recognised for many years, but research into similar cannabis-derived compounds, known as cannabinoids, has been limited.

15 Oct 2013

‘Targeted’ motivational interviewing may improve antipsychotic adherence

Motivational interviewing may help specific subgroups of patients with schizophrenia to adhere to their antipsychotic medication, a study suggests.

8 Oct 2013

Tel Aviv University researchers find chemicals in marijuana could help treat MS

Multiple sclerosis is an inflammatory disease in which the immune system attacks the nervous system. The result can be a wide range of debilitating motor, physical, and mental problems. No one knows why people get the disease or how to treat it.

8 Oct 2013

NAC amino acid may offer new treatment options for psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.

8 Oct 2013

Study: One in three teens with bipolar disorder develop substance abuse

A study published in the October 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that approximately one in three teens with bipolar disorder developed substance abuse, for the first time, during 4 years of follow-up.

3 Oct 2013

Endexx signs definitive agreement to acquire THCFinder.com and Herbal Care

Endexx Corporation is pleased to announce it has entered into a definitive agreement to acquire THCFinder.com and its parent company Herbal Care LLC. THCFinder.com is a leading player in Social Media and Cultural content in the Medical Marijuana industry, providing both relevant content and educational material to its user base related to the Medical Marijuana arena.

29 Sep 2013

Drug misuse predicts protracted hospital stay for schizophrenia patients

Patients hospitalized with schizophrenia have more severe symptoms and spend longer in hospital if they have a concurrent substance use disorder, report researchers.

26 Sep 2013

Adolescents with psychosis face long treatment delays

Adolescents have a duration of untreated psychosis that is approximately twice that seen in adults, UK study findings show.

20 Sep 2013

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.

18 Sep 2013

GrowLife opens 7th hydroponic retail in Santa Rosa, CA

GrowLife, Inc., a provider of highly effective indoor growing technologies and unique lifestyle brands, is pleased to announce that the Company will open its 7th hydroponic retail location in Santa Rosa, CA in October.

16 Sep 2013

GrowLife announces successful completion of 60 day marketing campaign using television ads

GrowLife, Inc. (OTCBB: PHOT), a provider of highly effective indoor growing technologies and unique lifestyle brands, is pleased to announce that the company has successfully completed a 60 day marketing campaign using strategically placed two minute television ads for its Phototron home growing unit.

31 Aug 2013

Opioid dependence causes greatest health burden of all illicit drugs

The first ever analysis of the global and regional prevalence of dependence upon the four major categories of illicit drugs – amphetamine, cannabis, cocaine, and opioids (such as heroin) – has revealed that opioid dependence causes the greatest health burden (overall death and illness) of all the illicit drugs. The results come from new analysis of the Global Burden of Disease Study 2010, and are published in The Lancet.

29 Aug 2013

Cannabis affects addiction processes in adolescent brain

The nature of the teenage brain makes users of cannabis amongst this population particularly at risk of developing addictive behaviors and suffering other long-term negative effects, according to researchers at the University of Montreal and New York's Icahn School of Medicine at Mount Sinai.

27 Aug 2013

Psychotic symptoms in people with schizophrenia caused by faulty 'switch' within brain

Scientists at The University of Nottingham have shown that psychotic symptoms experienced by people with schizophrenia could be caused by a faulty 'switch' within the brain.

22 Aug 2013

NTRR announces first phase of development on horticultural post-production system

As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.

13 Aug 2013

Cannabis News and Research

Latest Cannabis News and Research

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

New all-natural technology can eliminate molds and pesticides in cannabis products

Regular cannabis users have increased levels of impulsive behaviour, reveals research

Medical Cannabis Payment Systems announces marketing features for S2S Seed-to-Sale solution

Neutra working to help end staph infections in locker rooms

Study: Non-hallucinogenic components of cannabis may act as effective anti-cancer agents

‘Targeted’ motivational interviewing may improve antipsychotic adherence

Tel Aviv University researchers find chemicals in marijuana could help treat MS

NAC amino acid may offer new treatment options for psychiatric disorders

Study: One in three teens with bipolar disorder develop substance abuse

Endexx signs definitive agreement to acquire THCFinder.com and Herbal Care

Drug misuse predicts protracted hospital stay for schizophrenia patients

Adolescents with psychosis face long treatment delays

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GrowLife opens 7th hydroponic retail in Santa Rosa, CA

GrowLife announces successful completion of 60 day marketing campaign using television ads

Opioid dependence causes greatest health burden of all illicit drugs

Cannabis affects addiction processes in adolescent brain

Psychotic symptoms in people with schizophrenia caused by faulty 'switch' within brain

NTRR announces first phase of development on horticultural post-production system

Cannabis Testing & Analysis eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production